Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback